BUSINESS● LOW2h ago · Oct 26, 2026, 10:50 PM
Cumberland announces ifetroban NDA filing plan after shares plummet
Seeking Alpha Tech · global
Cumberland Pharmaceuticals has announced its plan for an ifetroban NDA filing following a significant drop in its share price. This indicates a key regulatory step for the company's drug development after market volatility.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS27m agoSimpson outlines 2026 operating margin of 20.0% to 20.5% as it readies additional steel-driven pricing actionsSeeking Alpha TechBUSINESS27m agoKforce expects Q4 revenue of $352M-$360M and EPS of $0.62-$0.70 as technology demand buildsSeeking Alpha Tech